A6191812
Notoginsenoside R1 , Analysis of standard products, ≥98%(HPLC) , 80418-24-2
Synonym(s):
(3β,6α,12β)-20-(β-D -Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-β-D -xylopyranosyl-β-D -glucopyranoside;Sanchinoside R1
| Pack Size | Price | Stock | Quantity |
| 20MG | RMB172.80 | In Stock |
|
| 100mg | RMB659.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 215～217℃ |
| Boiling point: | 1010.5±65.0 °C(Predicted) |
| Density | 1.39±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | H2O: soluble1mg/mL, clear, colorless |
| pka | 12.85±0.70(Predicted) |
| form | powder |
| color | white to off-white |
| InChIKey | LLPWNQMSUYAGQI-OOSPGMBYSA-N |
| LogP | 1.354 (est) |
Description and Uses
Notoginsenoside R1 acts as an anti-inflammatory agent, inhibiting TNF-α induced PAI-1 production in aortic smooth muscle cells in humans.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 24/25 |
| WGK Germany | 3 |
| HS Code | 29389090 |
| Hazardous Substances Data | 80418-24-2(Hazardous Substances Data) |
